What Is Recombivax HB?

Recombivax HB is the brand name of a hepatitis B vaccine manufactured by Merck. It is a noninfectious recombinant vaccine, meaning it does not contain live hepatitis B virus and cannot cause hepatitis B infection. The vaccine is approved for people of all ages, while the special Recombivax HB Dialysis Formulation is intended for adults receiving dialysis or preparing to begin dialysis.

The active material is hepatitis B surface antigen, commonly abbreviated as HBsAg. Scientists produce this protein by placing the genetic instructions for the surface antigen into yeast cells. The purified antigen is then combined with an aluminum-containing adjuvant that helps the immune system recognize it and build a stronger response. Because the product contains only a manufactured surface proteinnot the whole virusit cannot reproduce inside the body.

How Recombivax HB Works

After vaccination, the immune system develops antibodies against the hepatitis B surface antigen. These antibodies help recognize and neutralize hepatitis B virus if exposure occurs later. An anti-HBs antibody concentration of at least 10 mIU/mL is generally recognized as a protective response.

Most healthy people who respond to a complete hepatitis B vaccine series maintain long-term immune protection, even if measurable antibody levels decline over time. Routine booster doses are generally not required for healthy people with normal immune systems, although antibody monitoring and boosters may be recommended for dialysis patients and certain other high-risk groups.

What Is Recombivax HB Used For?

Recombivax HB is used to prevent infection caused by all known subtypes of hepatitis B virus. It does not treat active hepatitis B, cure chronic hepatitis B, or remove the virus from someone who is already infected. Think of it as a security system installed before the break-in, not a cleanup crew arriving afterward.

Hepatitis B can spread through infected blood and certain body fluids. Transmission may occur during childbirth, through sexual contact, by sharing needles or injection equipment, through occupational needlestick injuries, or by sharing blood-contaminated personal items such as razors and toothbrushes. Chronic infection can eventually lead to cirrhosis, liver failure, or liver cancer.

Who Should Receive a Hepatitis B Vaccine?

Current CDC guidance recommends hepatitis B vaccination for all infants, all unvaccinated children and adolescents younger than 19, and adults ages 19 through 59 who have not completed a vaccine series. Adults age 60 or older should be vaccinated when they have risk factors for hepatitis B, and adults in this age group without recognized risk factors may also receive the vaccine when they want protection.

Risk factors in older adults include having a sexual partner with hepatitis B, seeking evaluation or treatment for a sexually transmitted infection, having multiple sexual partners, using injected drugs, living with someone who has hepatitis B, working around blood, receiving dialysis, having diabetes, or being incarcerated.

Use After Possible Exposure

Recombivax HB may be used as part of post-exposure protection after contact with potentially infected blood or body fluids. Depending on the person’s vaccination history and the source of the exposure, a clinician may recommend both the vaccine and hepatitis B immune globulin, or HBIG. When both are given, they should be injected at different anatomical sites. Prompt medical evaluation is important because post-exposure decisions are time-sensitive.

Recombivax HB Dosage and Schedule

The correct Recombivax HB dosage depends on age, formulation, kidney function, and occasionally the vaccination schedule selected by the provider. A larger volume is not automatically “stronger” in the everyday sense; each formulation contains an antigen amount designed for a specific group.

Minimum Intervals Between Adult Doses

For the standard three-dose adult Recombivax HB series, CDC guidance specifies a minimum of four weeks between the first and second doses, eight weeks between the second and third doses, and 16 weeks between the first and third doses. These are minimum intervals, not a challenge to complete the series at record speed. The routine 0-, 1-, and 6-month schedule remains the usual approach.

What Happens If a Dose Is Late?

A delayed dose usually does not mean the entire hepatitis B vaccine series must be restarted. The next missing dose should generally be administered as soon as practical while respecting the required minimum intervals. Patients should bring any available vaccination records so the provider can determine which dose is actually needed.

How the Vaccine Is Administered

Recombivax HB is normally given as an intramuscular injection. For adults, adolescents, and children with sufficient muscle mass, the deltoid muscle of the upper arm is preferred. For infants younger than 1 year, the preferred location is the anterolateral thigh. The vaccine should not be injected into the buttock because that site has been associated with a weaker antibody response.

Subcutaneous administration may be considered for someone at significant risk of bleeding after an intramuscular injection, such as a person with hemophilia. However, the immune response may be lower, and local reactions may be more frequent, so this decision belongs in experienced medical hands.

Recombivax HB Side Effects

Most Recombivax HB side effects are mild and temporary. The most familiar complaint is soreness where the shot was given, often joined by fatigue or a headache that arrives without an invitation. Symptoms typically improve without specific treatment.

Common Side Effects in Adults

In clinical studies involving healthy adults, injection-site reactions were reported after approximately 17% of injections, while systemic reactions were reported after approximately 15%. Common reactions included:

• Pain, tenderness, redness, warmth, itching, or swelling at the injection site
• Fatigue or weakness
• Headache
• Low-grade fever
• General discomfort or malaise
• Nausea or diarrhea
• Sore throat or upper respiratory symptoms

Common Side Effects in Infants and Children

Reported reactions in younger children have included irritability, fever, diarrhea, fatigue, reduced appetite, and runny nose. Irritability can be difficult to measure scientifically in a baby, but parents generally recognize it as the mysterious transformation from “peaceful potato” to “tiny dissatisfied supervisor.”

Rare but Serious Reactions

Severe allergic reactions, including anaphylaxis, are rare but require immediate treatment. Warning signs may include difficulty breathing, wheezing, facial or throat swelling, widespread hives, severe dizziness, rapid heartbeat, or collapse. These symptoms require emergency medical care. Vaccination facilities are expected to have appropriate treatment available for allergic reactions.

Postmarketing reports have included neurological, autoimmune, skin, blood, and cardiovascular events. However, these reports are submitted voluntarily, their true frequency cannot reliably be calculated, and their appearance after vaccination does not by itself establish that the vaccine caused the event. Timing is evidence worth investigating, but it is not a magical certificate of causation.

When to Contact a Healthcare Professional

Contact a medical professional if a reaction is unusually intense, lasts longer than expected, continues to worsen, or includes persistent high fever, severe weakness, a spreading rash, unusual bruising, numbness, muscle weakness, or other concerning symptoms. Call emergency services for breathing difficulty, facial swelling, fainting, or signs of anaphylaxis.

Warnings and Who Should Not Receive Recombivax HB

Severe Allergy to a Previous Dose or Vaccine Component

Recombivax HB should not be administered to someone who previously experienced a severe allergic reaction to a hepatitis B-containing vaccine or to an ingredient in Recombivax HB, including yeast. The vial stopper, syringe plunger stopper, and tip cap may contain dry natural latex rubber, so patients with significant latex sensitivity should alert the vaccination provider before the product is prepared.

Premature and Low-Birth-Weight Infants

Special timing rules apply to infants weighing less than 2,000 grams, or about 4 pounds 6 ounces. When the mother is confirmed HBsAg-negative, vaccination may be delayed until the infant reaches 1 month of age or leaves the hospital. If the mother is HBsAg-positive or her status is unknown, the infant should receive hepatitis B vaccine and HBIG according to perinatal prevention recommendations. Premature infants may also need monitoring because apnea has occasionally followed intramuscular vaccination in this population.

Illness at the Time of Vaccination

A mild illness, such as a minor cold, is not automatically a reason to postpone vaccination. A provider may delay the dose when someone has a moderate or severe acute illness, especially when fever or symptoms could make it difficult to distinguish the illness from a vaccine reaction.

Recombivax HB Interactions

Other Vaccines

Recombivax HB may be given during the same visit as other recommended vaccines. However, the products must not be mixed in the same syringe or vial. Each injectable vaccine should use a separate syringe and a different injection site. Studies and CDC best-practice guidance support simultaneous administration of indicated vaccines in most circumstances.

Hepatitis B Immune Globulin

HBIG can be given at the same time as Recombivax HB when rapid post-exposure protection is needed, provided the products are injected at separate sites. HBIG supplies temporary antibodies, while the vaccine encourages the body to develop its own longer-lasting immune response.

Immunosuppressive Treatments

Recombivax HB is a non-live vaccine, so it cannot reproduce and cause hepatitis B in an immunocompromised patient. However, chemotherapy, high-dose corticosteroids, immune-modifying biologic drugs, transplant medicines, and certain medical conditions may weaken the antibody response. Timing, follow-up blood testing, an additional series, or a specialized dosing approach may be needed. Patients should not stop an immunosuppressive medicine solely to receive a vaccine unless the prescribing clinician directs them to do so.

Antibiotics and Everyday Medicines

Antibiotics generally do not interfere with non-live vaccines such as Recombivax HB. There are also no conventional liver-enzyme interactions comparable to those seen with many prescription medications. Nevertheless, patients should tell the provider about all medicines, supplements, allergies, and recent treatments so the complete clinical picture is available.

Temporary Interference With Blood Tests

Hepatitis B surface antigen from the vaccine may occasionally be detected temporarily in blood after vaccination. According to the product labeling, an HBsAg test performed within 28 days of vaccination may therefore be difficult to interpret. Patients undergoing hepatitis testing should tell the clinician when they received their most recent dose.

Pregnancy and Breastfeeding

Pregnancy and breastfeeding are not general reasons to avoid hepatitis B vaccination when vaccination is indicated. CDC guidance states that previously unvaccinated pregnant or breastfeeding patients should be vaccinated when appropriate. Available post-approval data for Recombivax HB have not suggested an increased risk of miscarriage or major birth defects, although the manufacturer notes that adequate, well-controlled trials specifically designed for pregnant women are unavailable.

Patients who are pregnant, planning pregnancy, or breastfeeding should discuss their vaccination history and hepatitis B risk with their obstetric clinician. This is especially important because hepatitis B infection during pregnancy creates a risk of transmission to the newborn during delivery.

How Effective Is Recombivax HB?

Recombivax HB stimulates protective antibody responses in most healthy recipients who complete the recommended series. Effectiveness can be lower in older adults, people receiving dialysis, people with certain chronic diseases, and those with weakened immune systems. The product label also cautions that vaccination may not protect every recipient and may not prevent illness in someone who was already infected but had not yet been diagnosed when vaccination occurred.

Routine post-vaccination antibody testing is not necessary for most healthy people. Testing is more commonly recommended when knowing the immune response will affect future medical decisions, such as for infants born to mothers with hepatitis B, healthcare workers with occupational exposure risk, dialysis patients, certain immunocompromised patients, and sexual partners of people with chronic hepatitis B.

How Much Does Recombivax HB Cost?

The cost of Recombivax HB varies by formulation, clinic, pharmacy, insurance network, administration fee, and geographic location. The price paid by a vaccine program or medical office is not necessarily the same as the final amount billed to an individual patient.

CDC’s April 2026 price information listed a private-sector price of about $28.52 for a pediatric prefilled dose and approximately $72.21 for an adult prefilled dose. Retail discount websites have recently shown adult cash prices beginning around $70 to $80 per dose, although availability and quoted prices can change without notice. A three-dose series may therefore cost substantially more than the advertised single-dose price once administration fees are included.

Insurance and Public Programs

Many private health plans cover recommended vaccines as preventive care when they are obtained from an in-network provider, but patients should verify coverage before the appointment. Eligible children may receive hepatitis B vaccines through the Vaccines for Children program. Medicare Part B covers hepatitis B vaccination for eligible beneficiaries, with no out-of-pocket cost when the provider accepts Medicare assignment.

Before paying cash, ask the clinic or pharmacy about insurance billing, administration fees, public health clinics, employer vaccination programs, manufacturer information, and legitimate prescription-discount services. The cheapest sticker price is not always the cheapest completed series.

Practical Experiences With the Recombivax HB Vaccination Process

The experience of receiving Recombivax HB is usually less dramatic than the medical terminology surrounding it. For many adults, the appointment begins with a brief review of vaccine records, health conditions, allergies, and possible hepatitis B risk factors. The injection itself takes seconds. The administrative detective work required to determine whether dose number two was given six months ago or six years ago may take longer.

A typical adult may notice a sore upper arm later that day. The discomfort often feels similar to a bruise and may become more noticeable when lifting the arm, sleeping on that side, or reaching for something on a high shelf. Some recipients experience fatigue, headache, mild fever, or a vague “I am operating at 83% today” feeling. These effects generally do not prevent ordinary activities, although scheduling a record-breaking shoulder workout immediately after the shot may be an unnecessary experiment.

Parents often describe a different pattern in babies and young children. The child may cry during the injection, settle quickly, and become sleepier or more irritable later. Feeding may briefly decrease, and a mild fever can occur. Keeping the child comfortable, offering fluids or regular feedings, and following the pediatrician’s advice about fever management are usually the practical priorities. Medication should not be given automatically before vaccination unless the child’s clinician recommends it.

The hardest part of a three-dose Recombivax HB series is often not the needleit is completing the schedule. Dose one feels important because it happens today. Dose two is only a month away and usually remains visible on the calendar. Dose three arrives months later, when the original appointment has become an archaeological artifact buried under work deadlines, school events, travel, and approximately 400 phone notifications.

A useful strategy is to schedule the next appointment before leaving the clinic, save a photograph of the vaccine record, and add multiple calendar reminders. Patients who lose track of the schedule should not assume they must begin again. A clinic or state immunization registry may be able to locate prior records, and delayed doses can generally be continued rather than restarted.

People receiving the dialysis formulation may have a more medicalized experience. They may need follow-up anti-HBs testing, periodic monitoring, and a booster or repeat vaccination when antibody levels fall below the recommended threshold. For these patients, the vaccine appointment is part of a larger infection-prevention plan rather than a one-time errand.

Healthcare workers may also pay closer attention to documentation and antibody testing because their jobs can involve needlesticks or exposure to blood. A completed series and documented immune response can make future post-exposure decisions faster and clearer. That paperwork may seem boring until the day it becomes extremely useful.

Anxiety about side effects is common, particularly when patients encounter long lists of postmarketing reports online. It helps to distinguish between common reactions demonstrated in controlled trials and events reported after vaccination without proof that the vaccine caused them. A symptom that occurs after a shot deserves appropriate attention, but “after” and “because of” are not interchangeable phrases.

Most importantly, individual experiences vary. One person may have no noticeable reaction, another may have a sore arm for two days, and a third may feel tired enough to rearrange an evening. Previous reactions, immune status, age, dialysis, pregnancy, and other medical circumstances can change the plan. Questions should be discussed with a qualified vaccination provider rather than answered by copying someone else’s experience from a comment section.

Frequently Asked Questions

Can Recombivax HB cause hepatitis B?

No. Recombivax HB is a noninfectious recombinant vaccine containing purified hepatitis B surface antigen. It does not contain live hepatitis B virus and cannot produce hepatitis B infection.

Can Recombivax HB treat someone who already has hepatitis B?

No. It is a preventive vaccine, not an antiviral treatment. Someone who tests positive for hepatitis B should receive medical evaluation and appropriate monitoring or treatment.

Can it be given with a flu or COVID-19 vaccine?

In most cases, indicated vaccines may be administered during the same visit using separate syringes and injection sites. The provider should review the current vaccination schedule and the patient’s medical history.

Is a booster required?

Routine boosters are generally not recommended for healthy people who completed the series and developed an adequate response. Dialysis patients and certain immunocompromised people may require antibody monitoring and additional doses.

Is Recombivax HB the only hepatitis B vaccine?

No. Other hepatitis B vaccine products are available in the United States, including vaccines with different formulations and schedules. Doses from different manufacturers can sometimes be used to complete a series, but the provider should verify that the resulting schedule satisfies current recommendations.

Conclusion

Recombivax HB is a widely used recombinant vaccine that helps prevent hepatitis B and its potentially serious long-term complications. Most recipients experience no reaction or only temporary soreness, fatigue, headache, irritability, or mild fever. Severe allergic reactions are rare but require immediate care.

The most important practical details are using the correct formulation, completing the recommended series, informing the provider about severe allergies and immune-suppressing treatments, and seeking prompt advice after a possible hepatitis B exposure. Price varies considerably, so insurance benefits, Medicare, public vaccine programs, and administration fees should be checked before paying out of pocket.

Editorial note: Medical recommendations and vaccine prices can change. This content was reviewed against current FDA labeling, CDC recommendations, manufacturer information, U.S. government coverage resources, and medically reviewed vaccine education materials available in July 2026. A healthcare professional should confirm recommendations for an individual patient.

SEO Information